Chujie Bai

机构：Peking University, Peking University Cancer Hospital, Ministry of Education · ORCID：0000-0003-1072-5219

发表论文 60 篇 · 总被引 479 次 · h-index 11

代表论文

• Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial (2024 · Clinical Cancer Research · 被引 15)
• Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial (2025 · Journal for ImmunoTherapy of Cancer · 被引 13)
• AOC3 accelerates lung metastasis of osteosarcoma by recruiting tumor-associated neutrophils, neutrophil extracellular trap formation and tumor vascularization (2024 · Heliyon · 被引 7)
• Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival (2024 · BMC Cancer · 被引 6)
• Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas (2025 · Cell Reports Medicine · 被引 5)
• Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicin (2024 · Anti-Cancer Drugs · 被引 4)